StonvexLoading…
StonvexStonvexStonvexCore line items from IDYA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $218.71M | $7.00M | $23.39M | $50.93M |
Operating Income | $-159.31M | $-326.98M | $-134.43M | $-62.50M |
Net Income | $-113.70M | $-274.48M | $-112.96M | $-58.66M |
EPS (Diluted) | $-1.28 | $-3.36 | $-1.96 | $-1.42 |
Total Assets | $1.11B | $1.12B | $649.32M | $387.97M |
Total Liabilities | $86.39M | $64.94M | $28.23M | $38.51M |
Cash & Equivalents | $112.83M | $84.38M | $157.02M | $68.63M |
Free Cash Flow OCF − CapEx | $-73.47M | $-251.44M | $-117.59M | $-90.62M |
Shares Outstanding | 87.80M | 86.50M | 65.04M | 48.19M |